A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 634 shares of LNTH stock, worth $54,809. This represents 0.01% of its overall portfolio holdings.

Number of Shares
634
Previous 1,913 66.86%
Holding current value
$54,809
Previous $154 Million 54.69%
% of portfolio
0.01%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $99,378 - $158,109
-1,279 Reduced 66.86%
634 $69.6 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $93,662 - $132,132
-1,591 Reduced 45.41%
1,913 $154 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $178,949 - $239,183
3,504 New
3,504 $218 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.94B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.